IGFBP2 expression predicts IDH-mutant glioma patient survival.

about

A GLO10 score for the prediction of prognosis in high grade gliomas.Isocitrate dehydrogenase 1 mutation subtypes at site 132 and their translational potential in glioma.IDH1 is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment

P2860

Q42378491-7838A770-E6B7-45C2-83AF-E8E40201BE0A Q47882259-9B73A46B-6E22-4F11-87BC-AB9B8B49B42C Q58738690-8FB93C8A-1E49-4FC5-81F0-3869C22F275B

P2860

IGFBP2 expression predicts IDH-mutant glioma patient survival.

Item

http://www.wikidata.org/entity/Q37702193

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

IGFBP2 expression predicts IDH-mutant glioma patient survival.

@en

IGFBP2 expression predicts IDH-mutant glioma patient survival.

@nl

type

Item

label

IGFBP2 expression predicts IDH-mutant glioma patient survival.

@en

IGFBP2 expression predicts IDH-mutant glioma patient survival.

@nl

prefLabel

IGFBP2 expression predicts IDH-mutant glioma patient survival.

@en

IGFBP2 expression predicts IDH-mutant glioma patient survival.

@nl

P1476

IGFBP2 expression predicts IDH-mutant glioma patient survival.

@en

P2093

Adam L Cohen

http://www.w3.org/2001/XMLSchema#string

Daniel W Fults

http://www.w3.org/2001/XMLSchema#string

Howard Colman

http://www.w3.org/2001/XMLSchema#string

Lin Eric Huang

http://www.w3.org/2001/XMLSchema#string

Randy L Jensen

http://www.w3.org/2001/XMLSchema#string

William T Couldwell

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Hallmarks of Cancer: The Next Generation

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

P304

191-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.13329

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27852048

http://www.w3.org/2001/XMLSchema#string

P932

5352106

http://www.w3.org/2001/XMLSchema#string

IGFBP2 expression predicts IDH-mutant glioma patient survival.

about

P2860

P2860

IGFBP2 expression predicts IDH-mutant glioma patient survival.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932